Bioavailability, Pharmacokinetics and Pharmacodynamics of Insulin Aspart following Subcutaneous Insulin Infusion (CSII) - Basal Rate Resolution.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms caih
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2009 Biomarkers information updated
- 13 Jul 2008 The expected completion date for this trial is now 1 Jul 2008.